SCHEMBL4869167

SCHEMBL4869167

c1ccc(-c2nc(-c3ccccn3)c(-c3cccnc3)[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 3/20 0.56
CYP2A6 P11509 1/20 0.55
MAPK13 O15264 7/20 0.52
MAPK12 P53778 7/20 0.52
MAPK11 Q15759 7/20 0.52
MAPK14 Q16539 7/20 0.52
RAF1 P04049 6/20 0.52
MAPK9 P45984 3/20 0.52
PIM1 P11309 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
CYP19A1 P11511 1/20 0.50
AURKA O14965 1/20 0.48
KDM4E B2RXH2 1/20 0.48
LDHA P00338 1/20 0.48
EPHX2 P34913 1/20 0.48
HPGDS O60760 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
PKM P14618 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18292652 0.85 MAPK14 (0.61) NPY5RMAPK13MAPK12MAPK11MAPK14
SCHEMBL9736817 0.79 MAPK13 (0.71) NPY5RMAPK13MAPK12MAPK11MAPK14
SCHEMBL6223466 0.77 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL28403314 0.76 MAPK13 (0.61) NPY5RMAPK13MAPK12MAPK11MAPK14
SCHEMBL4551941 0.75 MAPK13 (0.78) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL22229877 0.74 TGFBR1 (0.57) MAPK13MAPK12MAPK11MAPK14RAF1
[2,3'']Bipyridinyl SCHEMBL29486847 0.73 CYP2A6 (1.00) CYP2A6PIM1PIM2CYP19A1KDM4E
[2,3'']Bipyridinyl SCHEMBL29360744 0.73 CYP2A6 (1.00) CYP2A6PIM1PIM2CYP19A1KDM4E
[2,3'']Bipyridinyl SCHEMBL998601 0.73 CYP2A6 (1.00) CYP2A6PIM1PIM2CYP19A1KDM4E
[2,3'']Bipyridinyl SCHEMBL29389597 0.73 CYP2A6 (1.00) CYP2A6PIM1PIM2CYP19A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PDE5A, PDE3B, PDE12 NPY5R 1073/4885CYP2A6 157/4885MAPK13 1325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.